Sort
40,608 grants matching “prostate cancer”
Signaling Pathway Alterations in the Racial Disparity of Prostate Cancer
$351,092Peng Lee · New York University School Of Medicine · U01 · FY2016 · CA
Signaling Pathway Alterations in the Racial Disparity of Prostate Cancer
$351,090Peng Lee · New York University School Of Medicine · U01 · FY2012 · CA
Signaling Pathway Alterations in the Racial Disparity of Prostate Cancer
$351,088Peng Lee · New York University School Of Medicine · U01 · FY2015 · CA
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
$351,057Aaron Matthew Lebeau · University Of Minnesota · R01 · FY2020 · CA
Targeting CD133 for imaging and therapy in prostate cancer
$351,057Aaron Matthew Lebeau · University Of Minnesota · R01 · FY2019 · CA
Targeting CD133 for imaging and therapy in prostate cancer
$351,057Aaron Matthew Lebeau · University Of Minnesota · R01 · FY2020 · CA
Small Molecule Activators of PP2A (SMAPs) for Prostate Cancer Therapy
$351,024Goutham Narla · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
VITAMIN D--CHEMICAL AND RELATED STUDIES
$351,011University Of California Riverside · R01 · FY2000 · DK
CONSEQUENCES OF INHIBITION OF CELLULAR TELOMERASE
$351,000University Of Texas Sw Med Ctr/Dallas · R01 · FY2001 · CA
Administration Core
$351,000Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2021 · CA
WNT/BETA-CATENIN, FOXA2, AND CXCR4 AXIS CONTROLS PROSTATE CANCER PROGRESSION
$351,000Vanderbilt University, The · · FY2012 · Department of the Army
Michigan Prostate SPORE
$351,000Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2020 · CA
Targeting LSD1 in Neuroendocrine Prostate Cancer
$351,000Joshi James Alumkal · University Of Michigan At Ann Arbor · P50 · FY2020 · CA
Admin-Core-001
$351,000Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2022 · CA
Michigan Prostate SPORE
$351,000Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2022 · CA
CONSEQUENCES OF INHIBITION OF CELLULAR TELOMERASE
$351,000University Of Texas Sw Med Ctr/Dallas · R01 · FY2004 · CA
NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER: ROLE OF BONE MORPHOGENETIC PROTEIN-6 AND MACROPHAGES.
$351,000Umdnj-Robert Wood Johnson Medical School · · FY2009 · Department of the Army
CONSEQUENCES OF INHIBITION OF CELLULAR TELOMERASE
$351,000University Of Texas Sw Med Ctr/Dallas · R01 · FY2003 · CA
Michigan Prostate SPORE
$351,000Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2021 · CA
CONSEQUENCES OF INHIBITION OF CELLULAR TELOMERASE
$351,000University Of Texas Sw Med Ctr/Dallas · R01 · FY2002 · CA
Prevention and Treatment of Impotence
$350,996Tom F Lue · University Of California, San Francisco · R37 · FY2013 · DK
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
$350,990Marxa L. Figueiredo · Purdue University · R01 · FY2019 · CA
Development of Anatomical Patient Models to Facilitate MR-only Treatment Planning
$350,943Carri Kaye Glide-Hurst · Henry Ford Health System · R01 · FY2016 · CA
Prescription exercise for Older men with Urinary Disease (PROUD) pilot study
$350,886Scott Ryan Bauer · Northern California Institute/Res/Edu · R01 · FY2025 · DK
HCS to Identify Inhibitors and Disruptors of AR-TIF2 Interactions
$350,826Paul A. Johnston · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA